Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Date   Title
Milan - 23 December 2002   Recordati: Approval obtained in Italy for an innovative anti depressant drug
Milan - 12 December 2002   Recordati confirms 2002 target (EBIT +37%) and updates growth prospects
Milan - 6 December 2002   Recordati's U.S. licensee, Forest, updates status of lercanidipine regulatory submission
Milan, 30 October 2002   Recordati: Strong growth of sales and margins in the first nine months 2002
Milan, 24 October 2002   Recordati to co-market moxifloxacine, an important antibacterial drug, with Bayer
Milan, 7 October 2002   Recordati licenses an immuno-suppressant drug for Italy, France and Spain
Page 1  2  3  4    >>
 
  Top